Found 12 results
Author Title [ Type(Desc)] Year
Filters: Author is Hammel, K  [Clear All Filters]
Journal Article
H. Sen, Levy-Clarke, G., Faia, L., Li, Z., Yeh, S., Barron, K., Ryan, J., Hammel, K., and Nussenblatt, R., High-dose Daclizumab for the Treatment of Juvenile Idiopathic Arthritis-Associated Active Anterior Uveitis, Am J Ophthalmol, vol. 148, pp. 696-703.e1., 2009.
H. N. Sen, Sangave, A., Hammel, K., Levy-Clarke, G., and Nussenblatt, R. B., Infliximab for the Treatment of Active Scleritis, Can J Ophthalmol, vol. 44, pp. e9-e12, 2009.
H. N. Sen, Buggage, R., Hammel, K., Levy-Clarke, G., and Nussenblatt, R., Infliximab for the Treatment of Scleritis and Recalcitrant Uveitis, 2008.
W. T. Wong, Liang, K., Hammel, K., Coleman, H. R., and Chew, E. Y., Intravitreal Ranibizumab Therapy for Retinal Capillary Hemangioblastoma Related to von Hippel-Lindau Disease, Ophthalmology, vol. 115, pp. 1957-1964, 2008.
P. A. Petrou, Cunningham, D., Shimel, K., Harrington, M., Hammel, K., Cukras, C. A., Ferris, F. L., Chew, E. Y., and Wong, W. T., Intravitreal Sirolimus for the Treatment of Geographic Atrophy: Results of a Phase I/II Clinical Trial, Invest Ophthalmol Vis Sci, vol. 56, pp. 330-338, 2015.
E. Chew, Kim, J., Coleman, H., Aiello, L., Fish, G., Ip, M., Haller, J., Figueroa, M., Martin, D., Callanan, D., Avery, R., Hammel, K., and Thompson, D., Preliminary Assessment of Celecoxib and Microdiode Pulse Laser Treatment of Diabetic Macular Edema, Retina, vol. 30, no. 3, pp. 459-467, 2010.
W. Wong, Kam, W., Cunningham, D., Harrington, M., Hammel, K., Meyerle, C., Cukras, C., Chew, E., Sadda, S., and Ferris, F., Treatment of Geographic Atrophy by the Topical Administration of OT-551: Results of a Phase II Clinical Trial, Invest Ophthlmol Vis Sci, vol. 51, pp. 613-619, 2010.
W. T. Wong, Dresner, S., Forooghian, F., Glaser, T., Doss, L., Zhou, M., Cunningham, D., Shimel, K., Harrington, M., Hammel, K., Cukras, C., Ferris, F. L., and Chew, E. Y., Treatment of Geographic Atrophy with Subconjunctival Sirolimus: Results of a Phase I/II Clinical Trial, Invest Ophthalmol Vis Sci, vol. 54, pp. 2941-2950, 2013.